Eli Lilly to Acquire Morphic Holding for $3.2 Billion to Expand Immunology Pipeline

Eli Lilly to Acquire Morphic Holding for .2 Billion to Expand Immunology Pipeline

Eli Lilly and Company is set to acquire Morphic Holding, Inc. (NASDAQ: MORF), a biopharmaceutical company based in Waltham, MA, known for developing oral integrin therapies for serious chronic diseases. Lilly will commence a tender offer to acquire all outstanding shares of Morphic for $57 per share in cash, totaling approximately $3.2 billion. The transaction … Read more

Biostate AI Secures $4M in Funding to Advance Biodata Foundry Technology

Biostate AI Secures M in Funding to Advance Biodata Foundry Technology

Biostate AI, a scalable biodata foundry startup based in Palo Alto, CA, has raised $4 million in funding. The round was led by Matter Venture Partners, with participation from Vision Plus Capital, Catapult VC, the Caltech Seed Fund, Dario Amodei, Joris Poort, Michael Schnall-Levin , and Emily Leproust. Founded in 2023 and led by CEO … Read more

NALA Raises $40M in Series A Funding

NALA Raises M in Series A Funding

UK-based fintech company NALA has raised $40 million in Series A funding to support its global expansion and improve the reliability of payments to Africa by developing its payment rails. This follows NALA’s previous round of fundraising in 2022, bringing the company’s total funding to over $50 million. NALA aims to build payment solutions for … Read more

Ligand Acquires Apeiron Biologics for $100M, Expanding Oncology Portfolio

Ligand Acquires Apeiron Biologics for 0M, Expanding Oncology Portfolio

Ligand Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, has acquired Apeiron Biologics AG, a Vienna, Austria-based private biopharmaceutical company, for $100 million. This acquisition provides Ligand with the royalty rights to QARZIBA®, a commercial oncology drug marketed in 35 countries by Recordati S.p.A. Apeiron Biologics, led by CEO Peter Llewellyn-Davies, co-develops QARZIBA for … Read more

Apriori Bio Secures $1.1M Funding from CEPI to Enhance Viral Threat Innovations

Apriori Bio Secures .1M Funding from CEPI to Enhance Viral Threat Innovations

Apriori Bio, a biotechnology company based in Boston, MA, has raised $1.1 million in funding from CEPI. The funds will be used to advance Apriori Bio’s artificial intelligence platform, Octavia™. Apriori Bio, founded in 2020 by Flagship Pioneering and led by CEO Lovisa Afzelius, specializes in innovations against viral threats. The company’s Octavia platform surveys … Read more

Robinhood Acquires AI Investment Platform Pluto

Robinhood Acquires AI Investment Platform Pluto

Robinhood has acquired Pluto Capital Inc., a Los Angeles-based provider of an AI-powered investment research platform. The financial details of the deal were not disclosed. Pluto, founded and led by CEO Jacob Sansbury, is designed to empower retail investors through its AI-driven copilot. The platform offers real-time data including news articles, stock prices, company report … Read more

HarmonyCares Secures $200M to Enhance In-Home Care Services

HarmonyCares Secures 0M to Enhance In-Home Care Services

HarmonyCares, a provider of value-based in-home longitudinal care based in Troy, MI, has raised $200 million in a funding round led by General Catalyst, McKesson Ventures, and a national payor. K2 HealthVentures and existing investors Rubicon Founders, Valtruis, HLM Capital, and Oak HC/FT also participated. The company plans to use the funding to expand its … Read more

Accenture Completes Acquisition of Openstream Holdings

Accenture Completes Acquisition of Openstream Holdings

Accenture has finalized the acquisition of Japan-based Openstream Holdings and its subsidiaries, Open Stream and Neutral. The financial details of the deal were not disclosed. Initially announced on May 17, 2024, the acquisition brings approximately 1,000 cloud and digital experts into Accenture’s cloud and digital engineering and manufacturing teams. This addition is set to enhance … Read more

Alcemy Raises $10M to Advance Cement Decarbonization

Alcemy Raises M to Advance Cement Decarbonization

Berlin-based cement and concrete decarbonization startup Alcemy has raised $10 million to scale its innovative cement decarbonization solution. Founded in 2018 by Leopold Spenner and Dr. Robert Meyer, Alcemy aims to transform the concrete and cement industry into a digital, greener age. Alcemy’s AI platform directly addresses cement decarbonization by providing quality predictions throughout the … Read more

Family-Run Speech Therapy Startup Saltroad Secures £575k Pre-Seed Funding

Family-Run Speech Therapy Startup Saltroad Secures £575k Pre-Seed Funding

Saltroad, a children’s speech and language therapy (SLT) startup, has raised £575,000 in pre-seed funding. The investment, led by Techstart Ventures with participation from Ascension VC, will enable Saltroad to build a core team in Belfast and deliver SLT services across the UK. Key Goals for the Funding Addressing a Critical Need In the UK, … Read more